nodes	percent_of_prediction	percent_of_DWPC	metapath
Rescinnamine—ACE—obesity	0.317	1	CbGaD
Rescinnamine—SLC18A2—Benzphetamine—obesity	0.287	0.556	CbGbCtD
Rescinnamine—SLC18A2—Methamphetamine—obesity	0.229	0.444	CbGbCtD
Rescinnamine—ACE—tunica intima—obesity	0.00829	0.221	CbGeAlD
Rescinnamine—ACE—sympathetic nervous system—obesity	0.00744	0.198	CbGeAlD
Rescinnamine—ACE—autonomic nervous system—obesity	0.005	0.133	CbGeAlD
Rescinnamine—ACE—arm—obesity	0.00442	0.118	CbGeAlD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—CPB2—obesity	0.00413	0.103	CbGpPWpGaD
Rescinnamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A14—obesity	0.00218	0.0544	CbGpPWpGaD
Rescinnamine—Sunburn—Bupropion—obesity	0.0018	0.021	CcSEcCtD
Rescinnamine—Bullous eruption—Orlistat—obesity	0.00163	0.019	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—MBOAT4—obesity	0.00161	0.0402	CbGpPWpGaD
Rescinnamine—SLC18A2—Amine compound SLC transporters—SLC6A14—obesity	0.00151	0.0378	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—CPE—obesity	0.00143	0.0358	CbGpPWpGaD
Rescinnamine—Bursitis—Sibutramine—obesity	0.00129	0.015	CcSEcCtD
Rescinnamine—ACE—respiratory system—obesity	0.00129	0.0343	CbGeAlD
Rescinnamine—SLC18A2—adipose tissue—obesity	0.00127	0.0339	CbGeAlD
Rescinnamine—Skin irritation—Bupropion—obesity	0.00126	0.0146	CcSEcCtD
Rescinnamine—SLC18A2—Norepinephrine Neurotransmitter Release Cycle—SLC22A1—obesity	0.00124	0.0311	CbGpPWpGaD
Rescinnamine—SLC18A2—digestive system—obesity	0.0012	0.0319	CbGeAlD
Rescinnamine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—obesity	0.00119	0.0298	CbGpPWpGaD
Rescinnamine—SLC18A2—adrenal gland—obesity	0.00114	0.0304	CbGeAlD
Rescinnamine—Bursitis—Bupropion—obesity	0.00113	0.0131	CcSEcCtD
Rescinnamine—Osteoporosis—Sibutramine—obesity	0.00111	0.013	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—CPB2—obesity	0.00109	0.0272	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—FFAR4—obesity	0.00104	0.0259	CbGpPWpGaD
Rescinnamine—Hypothyroidism—Orlistat—obesity	0.00101	0.0117	CcSEcCtD
Rescinnamine—Tooth disorder—Orlistat—obesity	0.000996	0.0116	CcSEcCtD
Rescinnamine—Psoriasis—Sibutramine—obesity	0.000994	0.0116	CcSEcCtD
Rescinnamine—SLC18A2—endocrine gland—obesity	0.00099	0.0264	CbGeAlD
Rescinnamine—ACE—cardiovascular system—obesity	0.000986	0.0263	CbGeAlD
Rescinnamine—Hypothyroidism—Sibutramine—obesity	0.000974	0.0113	CcSEcCtD
Rescinnamine—Osteoporosis—Bupropion—obesity	0.000972	0.0113	CcSEcCtD
Rescinnamine—Tooth disorder—Sibutramine—obesity	0.000964	0.0112	CcSEcCtD
Rescinnamine—ACE—Metabolism of Angiotensinogen to Angiotensins—AGT—obesity	0.000938	0.0235	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—GH1—obesity	0.000923	0.0231	CbGpPWpGaD
Rescinnamine—Hypertrichosis—Topiramate—obesity	0.000913	0.0106	CcSEcCtD
Rescinnamine—ACE—ACE Inhibitor Pathway—AGT—obesity	0.000894	0.0224	CbGpPWpGaD
Rescinnamine—SLC18A2—liver—obesity	0.000893	0.0238	CbGeAlD
Rescinnamine—ACE—pituitary gland—obesity	0.000873	0.0232	CbGeAlD
Rescinnamine—ACE—adipose tissue—obesity	0.000869	0.0232	CbGeAlD
Rescinnamine—Angina pectoris—Phentermine—obesity	0.000864	0.01	CcSEcCtD
Rescinnamine—Tooth disorder—Bupropion—obesity	0.00084	0.00976	CcSEcCtD
Rescinnamine—Herpes zoster—Sibutramine—obesity	0.00083	0.00964	CcSEcCtD
Rescinnamine—SLC18A2—Amine compound SLC transporters—SLC22A1—obesity	0.000827	0.0207	CbGpPWpGaD
Rescinnamine—ACE—digestive system—obesity	0.000818	0.0218	CbGeAlD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD4—obesity	0.000806	0.0202	CbGpPWpGaD
Rescinnamine—Gingivitis—Sibutramine—obesity	0.000796	0.00925	CcSEcCtD
Rescinnamine—Abscess—Sibutramine—obesity	0.00079	0.00918	CcSEcCtD
Rescinnamine—ACE—adrenal gland—obesity	0.00078	0.0208	CbGeAlD
Rescinnamine—Acute coronary syndrome—Phentermine—obesity	0.000779	0.00905	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A7—obesity	0.000779	0.0195	CbGpPWpGaD
Rescinnamine—Myocardial infarction—Phentermine—obesity	0.000775	0.009	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—DPP4—obesity	0.000752	0.0188	CbGpPWpGaD
Rescinnamine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD2—obesity	0.000751	0.0188	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—GIP—obesity	0.000724	0.0181	CbGpPWpGaD
Rescinnamine—Herpes zoster—Bupropion—obesity	0.000724	0.00841	CcSEcCtD
Rescinnamine—Reserpine—SLC22A1—obesity	0.000721	0.276	CrCbGaD
Rescinnamine—Accidental injury—Sibutramine—obesity	0.000706	0.00821	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—PCSK1—obesity	0.000699	0.0175	CbGpPWpGaD
Rescinnamine—Gingivitis—Bupropion—obesity	0.000694	0.00807	CcSEcCtD
Rescinnamine—Eyelid oedema—Topiramate—obesity	0.000688	0.00799	CcSEcCtD
Rescinnamine—Cough increased—Sibutramine—obesity	0.000683	0.00793	CcSEcCtD
Rescinnamine—ACE—endocrine gland—obesity	0.000676	0.018	CbGeAlD
Rescinnamine—ACE—ACE Inhibitor Pathway—NOS3—obesity	0.000656	0.0164	CbGpPWpGaD
Rescinnamine—Vaginal inflammation—Orlistat—obesity	0.000646	0.0075	CcSEcCtD
Rescinnamine—Insomnia—Methamphetamine—obesity	0.000635	0.00737	CcSEcCtD
Rescinnamine—SLC18A2—Neurotransmitter Release Cycle—SLC22A1—obesity	0.000632	0.0158	CbGpPWpGaD
Rescinnamine—Dermatitis contact—Sibutramine—obesity	0.000618	0.00718	CcSEcCtD
Rescinnamine—Accidental injury—Bupropion—obesity	0.000616	0.00716	CcSEcCtD
Rescinnamine—Insomnia—Benzphetamine—obesity	0.000612	0.00711	CcSEcCtD
Rescinnamine—ACE—liver—obesity	0.00061	0.0162	CbGeAlD
Rescinnamine—Vaginal infection—Orlistat—obesity	0.00061	0.00708	CcSEcCtD
Rescinnamine—Constipation—Methamphetamine—obesity	0.0006	0.00697	CcSEcCtD
Rescinnamine—Cough increased—Bupropion—obesity	0.000595	0.00692	CcSEcCtD
Rescinnamine—Lacrimation increased—Bupropion—obesity	0.000591	0.00687	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A14—obesity	0.00059	0.0148	CbGpPWpGaD
Rescinnamine—Insomnia—Phendimetrazine—obesity	0.000558	0.00648	CcSEcCtD
Rescinnamine—Urticaria—Methamphetamine—obesity	0.000557	0.00648	CcSEcCtD
Rescinnamine—Hypertonia—Sibutramine—obesity	0.000548	0.00637	CcSEcCtD
Rescinnamine—Vaginal inflammation—Bupropion—obesity	0.000545	0.00633	CcSEcCtD
Rescinnamine—Urticaria—Benzphetamine—obesity	0.000538	0.00625	CcSEcCtD
Rescinnamine—Erythema—Diethylpropion—obesity	0.000537	0.00624	CcSEcCtD
Rescinnamine—Tooth disorder—Topiramate—obesity	0.000535	0.00622	CcSEcCtD
Rescinnamine—Hypertension—Phentermine—obesity	0.000533	0.0062	CcSEcCtD
Rescinnamine—Constipation—Phendimetrazine—obesity	0.000527	0.00613	CcSEcCtD
Rescinnamine—Hypersensitivity—Methamphetamine—obesity	0.000517	0.00601	CcSEcCtD
Rescinnamine—Vaginal infection—Bupropion—obesity	0.000514	0.00598	CcSEcCtD
Rescinnamine—Redness—Topiramate—obesity	0.000514	0.00597	CcSEcCtD
Rescinnamine—Yohimbine—HTR1B—obesity	0.000513	0.197	CrCbGaD
Rescinnamine—Seborrhoeic dermatitis—Topiramate—obesity	0.000509	0.00592	CcSEcCtD
Rescinnamine—Oedema—Phentermine—obesity	0.000504	0.00586	CcSEcCtD
Rescinnamine—Hypersensitivity—Benzphetamine—obesity	0.000499	0.00579	CcSEcCtD
Rescinnamine—Injury—Sibutramine—obesity	0.000494	0.00574	CcSEcCtD
Rescinnamine—Dermatitis bullous—Orlistat—obesity	0.00049	0.0057	CcSEcCtD
Rescinnamine—Abdominal pain—Phendimetrazine—obesity	0.000488	0.00567	CcSEcCtD
Rescinnamine—Hypertonia—Bupropion—obesity	0.000478	0.00555	CcSEcCtD
Rescinnamine—Insomnia—Phenylpropanolamine—obesity	0.000476	0.00554	CcSEcCtD
Rescinnamine—Dermatitis bullous—Sibutramine—obesity	0.000475	0.00552	CcSEcCtD
Rescinnamine—Dizziness—Methamphetamine—obesity	0.000464	0.00539	CcSEcCtD
Rescinnamine—Myalgia—Diethylpropion—obesity	0.000457	0.00532	CcSEcCtD
Rescinnamine—Insomnia—Phentermine—obesity	0.000456	0.0053	CcSEcCtD
Rescinnamine—Discomfort—Diethylpropion—obesity	0.000452	0.00525	CcSEcCtD
Rescinnamine—Constipation—Phenylpropanolamine—obesity	0.00045	0.00523	CcSEcCtD
Rescinnamine—Dizziness—Benzphetamine—obesity	0.000447	0.0052	CcSEcCtD
Rescinnamine—Gingivitis—Topiramate—obesity	0.000442	0.00514	CcSEcCtD
Rescinnamine—Headache—Methamphetamine—obesity	0.00044	0.00511	CcSEcCtD
Rescinnamine—Myalgia—Cimetidine—obesity	0.000435	0.00506	CcSEcCtD
Rescinnamine—ACE—ACE Inhibitor Pathway—TGFB1—obesity	0.000434	0.0109	CbGpPWpGaD
Rescinnamine—Constipation—Phentermine—obesity	0.000431	0.00501	CcSEcCtD
Rescinnamine—Injury—Bupropion—obesity	0.00043	0.005	CcSEcCtD
Rescinnamine—Headache—Benzphetamine—obesity	0.000424	0.00493	CcSEcCtD
Rescinnamine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—obesity	0.000421	0.0105	CbGpPWpGaD
Rescinnamine—Endocrine disorder—Topiramate—obesity	0.000419	0.00487	CcSEcCtD
Rescinnamine—Yohimbine—HTR2C—obesity	0.000418	0.16	CrCbGaD
Rescinnamine—Gastritis—Orlistat—obesity	0.000415	0.00482	CcSEcCtD
Rescinnamine—Dizziness—Phendimetrazine—obesity	0.000408	0.00474	CcSEcCtD
Rescinnamine—Influenza—Orlistat—obesity	0.000405	0.00471	CcSEcCtD
Rescinnamine—Nausea—Benzphetamine—obesity	0.000402	0.00467	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—GHRL—obesity	0.000402	0.0101	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—BCHE—obesity	0.000402	0.0101	CbGpPWpGaD
Rescinnamine—Gastritis—Sibutramine—obesity	0.000401	0.00467	CcSEcCtD
Rescinnamine—Urticaria—Phentermine—obesity	0.0004	0.00465	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Diethylpropion—obesity	0.0004	0.00464	CcSEcCtD
Rescinnamine—Abdominal pain—Phentermine—obesity	0.000399	0.00463	CcSEcCtD
Rescinnamine—Insomnia—Diethylpropion—obesity	0.000397	0.00461	CcSEcCtD
Rescinnamine—Influenza—Sibutramine—obesity	0.000392	0.00456	CcSEcCtD
Rescinnamine—Hypersensitivity—Phenylpropanolamine—obesity	0.000388	0.00451	CcSEcCtD
Rescinnamine—Headache—Phendimetrazine—obesity	0.000386	0.00449	CcSEcCtD
Rescinnamine—Skin discolouration—Topiramate—obesity	0.000384	0.00447	CcSEcCtD
Rescinnamine—Angina pectoris—Sibutramine—obesity	0.000382	0.00444	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Cimetidine—obesity	0.00038	0.00442	CcSEcCtD
Rescinnamine—Bronchitis—Sibutramine—obesity	0.000377	0.00438	CcSEcCtD
Rescinnamine—Lacrimation increased—Topiramate—obesity	0.000377	0.00438	CcSEcCtD
Rescinnamine—Constipation—Diethylpropion—obesity	0.000375	0.00436	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—TCF7L2—obesity	0.000374	0.00935	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—GCG—obesity	0.000367	0.00919	CbGpPWpGaD
Rescinnamine—Nausea—Phendimetrazine—obesity	0.000366	0.00426	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Sibutramine—obesity	0.000358	0.00416	CcSEcCtD
Rescinnamine—Constipation—Cimetidine—obesity	0.000357	0.00415	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC16A7—obesity	0.000354	0.00886	CbGpPWpGaD
Rescinnamine—Urinary tract infection—Orlistat—obesity	0.000351	0.00408	CcSEcCtD
Rescinnamine—Gastritis—Bupropion—obesity	0.00035	0.00407	CcSEcCtD
Rescinnamine—Urticaria—Diethylpropion—obesity	0.000348	0.00405	CcSEcCtD
Rescinnamine—Dizziness—Phenylpropanolamine—obesity	0.000348	0.00405	CcSEcCtD
Rescinnamine—Vaginal inflammation—Topiramate—obesity	0.000347	0.00403	CcSEcCtD
Rescinnamine—Yohimbine—SLC6A4—obesity	0.000347	0.133	CrCbGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GABRA6—obesity	0.000345	0.00864	CbGpPWpGaD
Rescinnamine—Yohimbine—DRD2—obesity	0.000345	0.132	CrCbGaD
Rescinnamine—Acute coronary syndrome—Sibutramine—obesity	0.000345	0.004	CcSEcCtD
Rescinnamine—Myocardial infarction—Sibutramine—obesity	0.000343	0.00398	CcSEcCtD
Rescinnamine—Influenza—Bupropion—obesity	0.000342	0.00397	CcSEcCtD
Rescinnamine—Urinary tract infection—Sibutramine—obesity	0.00034	0.00395	CcSEcCtD
Rescinnamine—Conjunctivitis—Sibutramine—obesity	0.00034	0.00395	CcSEcCtD
Rescinnamine—Sinusitis—Orlistat—obesity	0.000339	0.00394	CcSEcCtD
Rescinnamine—Dizziness—Phentermine—obesity	0.000333	0.00387	CcSEcCtD
Rescinnamine—Rash—Phenylpropanolamine—obesity	0.000332	0.00386	CcSEcCtD
Rescinnamine—Dermatitis—Phenylpropanolamine—obesity	0.000332	0.00386	CcSEcCtD
Rescinnamine—Bronchitis—Bupropion—obesity	0.000329	0.00382	CcSEcCtD
Rescinnamine—Sinusitis—Sibutramine—obesity	0.000328	0.00381	CcSEcCtD
Rescinnamine—Vaginal infection—Topiramate—obesity	0.000328	0.00381	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—obesity	0.000323	0.00809	CbGpPWpGaD
Rescinnamine—Pharyngitis—Orlistat—obesity	0.000322	0.00374	CcSEcCtD
Rescinnamine—Rash—Phentermine—obesity	0.000318	0.00369	CcSEcCtD
Rescinnamine—Dermatitis—Phentermine—obesity	0.000318	0.00369	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—GNB3—obesity	0.000317	0.00792	CbGpPWpGaD
Rescinnamine—Headache—Phentermine—obesity	0.000316	0.00367	CcSEcCtD
Rescinnamine—Rhinitis—Sibutramine—obesity	0.000315	0.00366	CcSEcCtD
Rescinnamine—Nausea—Phenylpropanolamine—obesity	0.000313	0.00364	CcSEcCtD
Rescinnamine—Hypoaesthesia—Sibutramine—obesity	0.000312	0.00363	CcSEcCtD
Rescinnamine—Photosensitivity reaction—Bupropion—obesity	0.000312	0.00363	CcSEcCtD
Rescinnamine—Pharyngitis—Sibutramine—obesity	0.000311	0.00362	CcSEcCtD
Rescinnamine—Hypersensitivity—Cimetidine—obesity	0.000307	0.00357	CcSEcCtD
Rescinnamine—Hypertonia—Topiramate—obesity	0.000304	0.00354	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—MBOAT4—obesity	0.000303	0.00759	CbGpPWpGaD
Rescinnamine—Acute coronary syndrome—Bupropion—obesity	0.0003	0.00349	CcSEcCtD
Rescinnamine—Nausea—Phentermine—obesity	0.000299	0.00348	CcSEcCtD
Rescinnamine—Myocardial infarction—Bupropion—obesity	0.000299	0.00347	CcSEcCtD
Rescinnamine—Conjunctivitis—Bupropion—obesity	0.000296	0.00344	CcSEcCtD
Rescinnamine—Urinary tract infection—Bupropion—obesity	0.000296	0.00344	CcSEcCtD
Rescinnamine—Dizziness—Diethylpropion—obesity	0.00029	0.00337	CcSEcCtD
Rescinnamine—Sinusitis—Bupropion—obesity	0.000286	0.00332	CcSEcCtD
Rescinnamine—Rash—Diethylpropion—obesity	0.000277	0.00321	CcSEcCtD
Rescinnamine—Dysgeusia—Orlistat—obesity	0.000276	0.00321	CcSEcCtD
Rescinnamine—Dermatitis—Diethylpropion—obesity	0.000276	0.00321	CcSEcCtD
Rescinnamine—Dizziness—Cimetidine—obesity	0.000276	0.00321	CcSEcCtD
Rescinnamine—Headache—Diethylpropion—obesity	0.000275	0.00319	CcSEcCtD
Rescinnamine—Rhinitis—Bupropion—obesity	0.000274	0.00319	CcSEcCtD
Rescinnamine—Back pain—Orlistat—obesity	0.000273	0.00317	CcSEcCtD
Rescinnamine—Hypoaesthesia—Bupropion—obesity	0.000272	0.00316	CcSEcCtD
Rescinnamine—Pharyngitis—Bupropion—obesity	0.000272	0.00316	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—CPE—obesity	0.00027	0.00677	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC6A14—obesity	0.000268	0.00671	CbGpPWpGaD
Rescinnamine—Dysgeusia—Sibutramine—obesity	0.000268	0.00311	CcSEcCtD
Rescinnamine—Yohimbine—HTR2A—obesity	0.000266	0.102	CrCbGaD
Rescinnamine—SLC18A2—Neuronal System—GABRA6—obesity	0.000264	0.00662	CbGpPWpGaD
Rescinnamine—Back pain—Sibutramine—obesity	0.000264	0.00307	CcSEcCtD
Rescinnamine—Rash—Cimetidine—obesity	0.000263	0.00306	CcSEcCtD
Rescinnamine—Dermatitis—Cimetidine—obesity	0.000263	0.00305	CcSEcCtD
Rescinnamine—Headache—Cimetidine—obesity	0.000261	0.00304	CcSEcCtD
Rescinnamine—Nausea—Diethylpropion—obesity	0.000261	0.00303	CcSEcCtD
Rescinnamine—Nausea—Cimetidine—obesity	0.000248	0.00288	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—AGT—obesity	0.000247	0.00617	CbGpPWpGaD
Rescinnamine—Cough—Orlistat—obesity	0.000246	0.00286	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GLUL—obesity	0.000246	0.00615	CbGpPWpGaD
Rescinnamine—ACE—Peptide hormone metabolism—LEP—obesity	0.000242	0.00605	CbGpPWpGaD
Rescinnamine—Myalgia—Orlistat—obesity	0.00024	0.00279	CcSEcCtD
Rescinnamine—Cough—Sibutramine—obesity	0.000238	0.00277	CcSEcCtD
Rescinnamine—Discomfort—Orlistat—obesity	0.000237	0.00276	CcSEcCtD
Rescinnamine—Hypertension—Sibutramine—obesity	0.000236	0.00274	CcSEcCtD
Rescinnamine—Dysgeusia—Bupropion—obesity	0.000233	0.00271	CcSEcCtD
Rescinnamine—Myalgia—Sibutramine—obesity	0.000233	0.0027	CcSEcCtD
Rescinnamine—Oedema—Orlistat—obesity	0.00023	0.00268	CcSEcCtD
Rescinnamine—Back pain—Bupropion—obesity	0.00023	0.00268	CcSEcCtD
Rescinnamine—Discomfort—Sibutramine—obesity	0.00023	0.00267	CcSEcCtD
Rescinnamine—Infection—Orlistat—obesity	0.000229	0.00266	CcSEcCtD
Rescinnamine—Gastritis—Topiramate—obesity	0.000223	0.00259	CcSEcCtD
Rescinnamine—Oedema—Sibutramine—obesity	0.000223	0.00259	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC9A3—obesity	0.000222	0.00556	CbGpPWpGaD
Rescinnamine—Infection—Sibutramine—obesity	0.000222	0.00257	CcSEcCtD
Rescinnamine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—obesity	0.000218	0.00547	CbGpPWpGaD
Rescinnamine—Angina pectoris—Topiramate—obesity	0.000212	0.00247	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—HK2—obesity	0.000212	0.00531	CbGpPWpGaD
Rescinnamine—Musculoskeletal discomfort—Orlistat—obesity	0.00021	0.00244	CcSEcCtD
Rescinnamine—Bronchitis—Topiramate—obesity	0.000209	0.00243	CcSEcCtD
Rescinnamine—Insomnia—Orlistat—obesity	0.000208	0.00242	CcSEcCtD
Rescinnamine—Cough—Bupropion—obesity	0.000208	0.00242	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—POMC—obesity	0.000208	0.0052	CbGpPWpGaD
Rescinnamine—Paraesthesia—Orlistat—obesity	0.000207	0.0024	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—INS—obesity	0.000206	0.00517	CbGpPWpGaD
Rescinnamine—Hypertension—Bupropion—obesity	0.000206	0.00239	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—CS—obesity	0.000205	0.00513	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CPB2—obesity	0.000205	0.00513	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000203	0.00509	CbGpPWpGaD
Rescinnamine—Musculoskeletal discomfort—Sibutramine—obesity	0.000203	0.00236	CcSEcCtD
Rescinnamine—Myalgia—Bupropion—obesity	0.000203	0.00236	CcSEcCtD
Rescinnamine—Insomnia—Sibutramine—obesity	0.000202	0.00234	CcSEcCtD
Rescinnamine—Discomfort—Bupropion—obesity	0.0002	0.00233	CcSEcCtD
Rescinnamine—Paraesthesia—Sibutramine—obesity	0.0002	0.00233	CcSEcCtD
Rescinnamine—ACE—Peptide hormone metabolism—IGF1—obesity	0.0002	0.005	CbGpPWpGaD
Rescinnamine—Photosensitivity reaction—Topiramate—obesity	0.000199	0.00231	CcSEcCtD
Rescinnamine—Pain—Orlistat—obesity	0.000197	0.00229	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—AQP7—obesity	0.000197	0.00492	CbGpPWpGaD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—STAT3—obesity	0.000196	0.00491	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGFBP2—obesity	0.000196	0.00489	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—FFAR4—obesity	0.000196	0.00489	CbGpPWpGaD
Rescinnamine—Oedema—Bupropion—obesity	0.000194	0.00226	CcSEcCtD
Rescinnamine—Infection—Bupropion—obesity	0.000193	0.00224	CcSEcCtD
Rescinnamine—Constipation—Sibutramine—obesity	0.000191	0.00222	CcSEcCtD
Rescinnamine—Pain—Sibutramine—obesity	0.000191	0.00222	CcSEcCtD
Rescinnamine—Conjunctivitis—Topiramate—obesity	0.000189	0.00219	CcSEcCtD
Rescinnamine—Urinary tract infection—Topiramate—obesity	0.000189	0.00219	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—GLUL—obesity	0.000188	0.00471	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Orlistat—obesity	0.000188	0.00219	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—GFPT1—obesity	0.000187	0.00469	CbGpPWpGaD
Rescinnamine—Urticaria—Orlistat—obesity	0.000183	0.00213	CcSEcCtD
Rescinnamine—Gastrointestinal pain—Sibutramine—obesity	0.000182	0.00212	CcSEcCtD
Rescinnamine—Sinusitis—Topiramate—obesity	0.000182	0.00212	CcSEcCtD
Rescinnamine—Abdominal pain—Orlistat—obesity	0.000182	0.00212	CcSEcCtD
Rescinnamine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—obesity	0.000182	0.00455	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—SLC22A1—obesity	0.000181	0.00454	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC16A7—obesity	0.00018	0.0045	CbGpPWpGaD
Rescinnamine—Urticaria—Sibutramine—obesity	0.000177	0.00206	CcSEcCtD
Rescinnamine—Musculoskeletal discomfort—Bupropion—obesity	0.000177	0.00206	CcSEcCtD
Rescinnamine—Abdominal pain—Sibutramine—obesity	0.000176	0.00205	CcSEcCtD
Rescinnamine—Insomnia—Bupropion—obesity	0.000176	0.00204	CcSEcCtD
Rescinnamine—Rhinitis—Topiramate—obesity	0.000175	0.00203	CcSEcCtD
Rescinnamine—Paraesthesia—Bupropion—obesity	0.000175	0.00203	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—GH1—obesity	0.000174	0.00436	CbGpPWpGaD
Rescinnamine—Hypoaesthesia—Topiramate—obesity	0.000173	0.00202	CcSEcCtD
Rescinnamine—Pharyngitis—Topiramate—obesity	0.000173	0.00201	CcSEcCtD
Rescinnamine—Hypersensitivity—Orlistat—obesity	0.00017	0.00197	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—LCN2—obesity	0.000167	0.00418	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—HK1—obesity	0.000166	0.00416	CbGpPWpGaD
Rescinnamine—Pain—Bupropion—obesity	0.000166	0.00193	CcSEcCtD
Rescinnamine—Constipation—Bupropion—obesity	0.000166	0.00193	CcSEcCtD
Rescinnamine—Hypersensitivity—Sibutramine—obesity	0.000164	0.00191	CcSEcCtD
Rescinnamine—Pruritus—Orlistat—obesity	0.000163	0.00189	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—KCNMA1—obesity	0.000159	0.00398	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Bupropion—obesity	0.000159	0.00185	CcSEcCtD
Rescinnamine—Pruritus—Sibutramine—obesity	0.000158	0.00183	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—COX7C—obesity	0.000157	0.00393	CbGpPWpGaD
Rescinnamine—Urticaria—Bupropion—obesity	0.000154	0.00179	CcSEcCtD
Rescinnamine—Abdominal pain—Bupropion—obesity	0.000154	0.00179	CcSEcCtD
Rescinnamine—Dizziness—Orlistat—obesity	0.000152	0.00177	CcSEcCtD
Rescinnamine—Erythema—Topiramate—obesity	0.000152	0.00176	CcSEcCtD
Rescinnamine—Dysgeusia—Topiramate—obesity	0.000149	0.00173	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—STS—obesity	0.000148	0.00371	CbGpPWpGaD
Rescinnamine—Dizziness—Sibutramine—obesity	0.000147	0.00171	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC22A1—obesity	0.000147	0.00368	CbGpPWpGaD
Rescinnamine—Back pain—Topiramate—obesity	0.000147	0.00171	CcSEcCtD
Rescinnamine—Rash—Orlistat—obesity	0.000145	0.00169	CcSEcCtD
Rescinnamine—Dermatitis—Orlistat—obesity	0.000145	0.00169	CcSEcCtD
Rescinnamine—Headache—Orlistat—obesity	0.000144	0.00168	CcSEcCtD
Rescinnamine—Hypersensitivity—Bupropion—obesity	0.000143	0.00166	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GABRA6—obesity	0.000142	0.00356	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—FTL—obesity	0.000142	0.00356	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—DPP4—obesity	0.000142	0.00355	CbGpPWpGaD
Rescinnamine—Rash—Sibutramine—obesity	0.000141	0.00163	CcSEcCtD
Rescinnamine—Dermatitis—Sibutramine—obesity	0.00014	0.00163	CcSEcCtD
Rescinnamine—Headache—Sibutramine—obesity	0.00014	0.00162	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—SLC22A1—obesity	0.000139	0.00348	CbGpPWpGaD
Rescinnamine—Pruritus—Bupropion—obesity	0.000138	0.0016	CcSEcCtD
Rescinnamine—Nausea—Orlistat—obesity	0.000137	0.00159	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—GIP—obesity	0.000137	0.00342	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC6A14—obesity	0.000136	0.00341	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—BCHE—obesity	0.000134	0.00335	CbGpPWpGaD
Rescinnamine—Nausea—Sibutramine—obesity	0.000132	0.00154	CcSEcCtD
Rescinnamine—Cough—Topiramate—obesity	0.000132	0.00154	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—PCSK1—obesity	0.000132	0.0033	CbGpPWpGaD
Rescinnamine—Hypertension—Topiramate—obesity	0.000131	0.00152	CcSEcCtD
Rescinnamine—Myalgia—Topiramate—obesity	0.000129	0.0015	CcSEcCtD
Rescinnamine—Dizziness—Bupropion—obesity	0.000129	0.00149	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—GCK—obesity	0.000128	0.00319	CbGpPWpGaD
Rescinnamine—Discomfort—Topiramate—obesity	0.000128	0.00148	CcSEcCtD
Rescinnamine—Oedema—Topiramate—obesity	0.000124	0.00144	CcSEcCtD
Rescinnamine—Infection—Topiramate—obesity	0.000123	0.00143	CcSEcCtD
Rescinnamine—Rash—Bupropion—obesity	0.000123	0.00142	CcSEcCtD
Rescinnamine—Dermatitis—Bupropion—obesity	0.000122	0.00142	CcSEcCtD
Rescinnamine—Headache—Bupropion—obesity	0.000122	0.00142	CcSEcCtD
Rescinnamine—Nausea—Bupropion—obesity	0.000115	0.00134	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC9A3—obesity	0.000113	0.00283	CbGpPWpGaD
Rescinnamine—Musculoskeletal discomfort—Topiramate—obesity	0.000113	0.00131	CcSEcCtD
Rescinnamine—Insomnia—Topiramate—obesity	0.000112	0.0013	CcSEcCtD
Rescinnamine—Paraesthesia—Topiramate—obesity	0.000111	0.00129	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—HK2—obesity	0.000108	0.0027	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—COMT—obesity	0.000107	0.00268	CbGpPWpGaD
Rescinnamine—Constipation—Topiramate—obesity	0.000106	0.00123	CcSEcCtD
Rescinnamine—Pain—Topiramate—obesity	0.000106	0.00123	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—GNB3—obesity	0.000106	0.00264	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC27A1—obesity	0.000103	0.00258	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGFBP1—obesity	0.000103	0.00257	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—BCHE—obesity	0.000103	0.00257	CbGpPWpGaD
Rescinnamine—Gastrointestinal pain—Topiramate—obesity	0.000101	0.00118	CcSEcCtD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—SLC2A4—obesity	9.93e-05	0.00248	CbGpPWpGaD
Rescinnamine—Urticaria—Topiramate—obesity	9.84e-05	0.00114	CcSEcCtD
Rescinnamine—Abdominal pain—Topiramate—obesity	9.79e-05	0.00114	CcSEcCtD
Rescinnamine—Hypersensitivity—Topiramate—obesity	9.12e-05	0.00106	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—IGFBP3—obesity	8.92e-05	0.00223	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TRPV1—obesity	8.78e-05	0.0022	CbGpPWpGaD
Rescinnamine—Pruritus—Topiramate—obesity	8.76e-05	0.00102	CcSEcCtD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—HK1—obesity	8.45e-05	0.00212	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—COMT—obesity	8.2e-05	0.00205	CbGpPWpGaD
Rescinnamine—Dizziness—Topiramate—obesity	8.19e-05	0.000952	CcSEcCtD
Rescinnamine—SLC18A2—Neuronal System—GNB3—obesity	8.09e-05	0.00202	CbGpPWpGaD
Rescinnamine—Rash—Topiramate—obesity	7.81e-05	0.000907	CcSEcCtD
Rescinnamine—Dermatitis—Topiramate—obesity	7.8e-05	0.000906	CcSEcCtD
Rescinnamine—Headache—Topiramate—obesity	7.76e-05	0.000902	CcSEcCtD
Rescinnamine—SLC18A2—Transmission across Chemical Synapses—PRKCB—obesity	7.6e-05	0.0019	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—BCHE—obesity	7.58e-05	0.0019	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—GHRL—obesity	7.58e-05	0.0019	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC22A1—obesity	7.47e-05	0.00187	CbGpPWpGaD
Rescinnamine—Nausea—Topiramate—obesity	7.36e-05	0.000855	CcSEcCtD
Rescinnamine—ACE—Metabolism of proteins—TCF7L2—obesity	7.06e-05	0.00177	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—GCG—obesity	6.94e-05	0.00174	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PRKAR2B—obesity	6.89e-05	0.00172	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GCK—obesity	6.49e-05	0.00162	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—PLG—obesity	6.45e-05	0.00161	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CETP—obesity	6.26e-05	0.00157	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TF—obesity	6.19e-05	0.00155	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—GNB3—obesity	5.98e-05	0.0015	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—TFRC—obesity	5.93e-05	0.00148	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGF2—obesity	5.87e-05	0.00147	CbGpPWpGaD
Rescinnamine—SLC18A2—Neuronal System—PRKCB—obesity	5.82e-05	0.00146	CbGpPWpGaD
Rescinnamine—SLC18A2—SLC-mediated transmembrane transport—ALB—obesity	5.11e-05	0.00128	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—SLC2A4—obesity	5.04e-05	0.00126	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—CYCS—obesity	4.98e-05	0.00125	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—NCOA1—obesity	4.81e-05	0.0012	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PLG—obesity	4.69e-05	0.00117	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—AGT—obesity	4.66e-05	0.00117	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—LEP—obesity	4.56e-05	0.00114	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GNB3—obesity	4.35e-05	0.00109	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—HMOX1—obesity	4.33e-05	0.00108	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—F2—obesity	4.3e-05	0.00108	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—GNAS—obesity	4.23e-05	0.00106	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—APOB—obesity	4.15e-05	0.00104	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—POMC—obesity	3.92e-05	0.000981	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—INS—obesity	3.9e-05	0.000975	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—CCL2—obesity	3.84e-05	0.00096	CbGpPWpGaD
Rescinnamine—ACE—Metabolism of proteins—IGF1—obesity	3.77e-05	0.000943	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—PPARA—obesity	3.5e-05	0.000875	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—APOA1—obesity	3.28e-05	0.000821	CbGpPWpGaD
Rescinnamine—SLC18A2—Transmembrane transport of small molecules—ALB—obesity	2.6e-05	0.00065	CbGpPWpGaD
